News & Updates

First-line methotrexate on par with prednisone for sarcoidosis
First-line methotrexate on par with prednisone for sarcoidosis
18 Jun 2025 byStephen Padilla

The use of methotrexate as a first line of treatment for patients with pulmonary sarcoidosis delivers similar efficacy to prednisone as measured by forced vital capacity after 24 weeks, results of the PREDMETH trial have shown.

First-line methotrexate on par with prednisone for sarcoidosis
18 Jun 2025